List of Tables
    Table 1. Ocular Drug Delivery CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Ocular Drug Delivery Market Trends
    Table 3. Ocular Drug Delivery Market Drivers
    Table 4. Ocular Drug Delivery Market Challenges
    Table 5. Ocular Drug Delivery Market Restraints
    Table 6. Global Ocular Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ocular Drug Delivery Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ocular Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ocular Drug Delivery Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ocular Drug Delivery Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ocular Drug Delivery Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Ocular Drug Delivery Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Ocular Drug Delivery Sales by Manufacturer, (K Doses), 2017-2022
    Table 14. Global Ocular Drug Delivery Sales Share by Manufacturer, 2017-2022
    Table 15. Global Ocular Drug Delivery Price by Manufacturer (2017-2022) & (USD/Dose)
    Table 16. Global Ocular Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Ocular Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocular Drug Delivery as of 2021)
    Table 18. Top Players of Ocular Drug Delivery in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Ocular Drug Delivery Product Type
    Table 20. Date of International Manufacturers Enter into Ocular Drug Delivery Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Ocular Drug Delivery Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Ocular Drug Delivery Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Ocular Drug Delivery Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Ocular Drug Delivery Sales by Players, (K Doses), 2020, 2021 & 2022
    Table 26. United States Ocular Drug Delivery Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Ocular Drug Delivery Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Ocular Drug Delivery Sales in Volume by Region (2017-2022) & (K Doses)
    Table 29. Global Ocular Drug Delivery Sales in Volume Forecast by Region (2023-2028) & (K Doses)
    Table 30. Global Ocular Drug Delivery Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Ocular Drug Delivery Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
    Table 33. North America Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Ocular Drug Delivery Sales in Volume by Region (2017-2028) & (K Doses)
    Table 35. Asia Pacific Ocular Drug Delivery Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
    Table 37. Europe Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
    Table 39. Latin Americaa Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Ocular Drug Delivery Sales in Volume by Country (2017-2028) & (K Doses)
    Table 41. Middle East and Africa Ocular Drug Delivery Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. OCULAR THERAPEUTIX, INC Corporation Information
    Table 43. OCULAR THERAPEUTIX, INC Description and Business Overview
    Table 44. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 45. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product
    Table 46. OCULAR THERAPEUTIX, INC Recent Development
    Table 47. Alimera Sciences Corporation Information
    Table 48. Alimera Sciences Description and Business Overview
    Table 49. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 50. Alimera Sciences Product
    Table 51. Alimera Sciences Recent Development
    Table 52. Allergan, Plc Corporation Information
    Table 53. Allergan, Plc Description and Business Overview
    Table 54. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 55. Allergan, Plc Product
    Table 56. Allergan, Plc Recent Development
    Table 57. EyeGate Pharma Corporation Information
    Table 58. EyeGate Pharma Description and Business Overview
    Table 59. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 60. EyeGate Pharma Product
    Table 61. EyeGate Pharma Recent Development
    Table 62. Valeant Pharmaceuticals International, Inc Corporation Information
    Table 63. Valeant Pharmaceuticals International, Inc Description and Business Overview
    Table 64. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 65. Valeant Pharmaceuticals International, Inc Product
    Table 66. Valeant Pharmaceuticals International, Inc Recent Development
    Table 67. Envisia Therapeutics Corporation Information
    Table 68. Envisia Therapeutics Description and Business Overview
    Table 69. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 70. Envisia Therapeutics Product
    Table 71. Envisia Therapeutics Recent Development
    Table 72. Clearside Biomedical Corporation Information
    Table 73. Clearside Biomedical Description and Business Overview
    Table 74. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 75. Clearside Biomedical Product
    Table 76. Clearside Biomedical Recent Development
    Table 77. Graybug Vision Inc Corporation Information
    Table 78. Graybug Vision Inc Description and Business Overview
    Table 79. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 80. Graybug Vision Inc Product
    Table 81. Graybug Vision Inc Recent Development
    Table 82. Taiwan Liposome Company Corporation Information
    Table 83. Taiwan Liposome Company Description and Business Overview
    Table 84. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 85. Taiwan Liposome Company Product
    Table 86. Taiwan Liposome Company Recent Development
    Table 87. Santen Pharmaceutical Corporation Information
    Table 88. Santen Pharmaceutical Description and Business Overview
    Table 89. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 90. Santen Pharmaceutical Product
    Table 91. Santen Pharmaceutical Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Ocular Drug Delivery Customers List
    Table 95. Ocular Drug Delivery Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ocular Drug Delivery Product Picture
    Figure 2. Global Ocular Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ocular Drug Delivery Market Size 2017-2028 (US$ Million)
    Figure 4. Global Ocular Drug Delivery Sales 2017-2028 (K Doses)
    Figure 5. United States Ocular Drug Delivery Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Ocular Drug Delivery Market Size 2017-2028 (US$ Million)
    Figure 7. United States Ocular Drug Delivery Sales 2017-2028 (K Doses)
    Figure 8. United States Ocular Drug Delivery Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Ocular Drug Delivery Market Share in Global, in Volume (K Doses) 2017-2028
    Figure 10. Ocular Drug Delivery Report Years Considered
    Figure 11. Product Picture of Ocular Insert
    Figure 12. Product Picture of Iontophoresis
    Figure 13. Product Picture of Intraocular Implants
    Figure 14. Product Picture of In Situ Gel & Punctal Plugs
    Figure 15. Product Picture of Others
    Figure 16. Global Ocular Drug Delivery Market Share by Type in 2022 & 2028
    Figure 17. Global Ocular Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Ocular Drug Delivery Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Ocular Drug Delivery Sales by Type (2017-2028) & (K Doses)
    Figure 20. Global Ocular Drug Delivery Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Ocular Drug Delivery Price by Type (2017-2028) & (USD/Dose)
    Figure 22. United States Ocular Drug Delivery Market Share by Type in 2022 & 2028
    Figure 23. United States Ocular Drug Delivery Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Ocular Drug Delivery Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Ocular Drug Delivery Sales by Type (2017-2028) & (K Doses)
    Figure 26. United States Ocular Drug Delivery Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Ocular Drug Delivery Price by Type (2017-2028) & (USD/Dose)
    Figure 28. Product Picture of Hospitals
    Figure 29. Product Picture of Ambulatory Surgical Centers
    Figure 30. Product Picture of Ophthalmic Clinics
    Figure 31. Product Picture of Homecare Settings
    Figure 32. Global Ocular Drug Delivery Market Share by Application in 2022 & 2028
    Figure 33. Global Ocular Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 34. Global Ocular Drug Delivery Sales Market Share in Value by Application (2017-2028)
    Figure 35. Global Ocular Drug Delivery Sales by Application (2017-2028) & (K Doses)
    Figure 36. Global Ocular Drug Delivery Sales Market Share in Volume by Application (2017-2028)
    Figure 37. Global Ocular Drug Delivery Price by Application (2017-2028) & (USD/Dose)
    Figure 38. United States Ocular Drug Delivery Market Share by Application in 2022 & 2028
    Figure 39. United States Ocular Drug Delivery Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 40. United States Ocular Drug Delivery Sales Market Share in Value by Application (2017-2028)
    Figure 41. United States Ocular Drug Delivery Sales by Application (2017-2028) & (K Doses)
    Figure 42. United States Ocular Drug Delivery Sales Market Share in Volume by Application (2017-2028)
    Figure 43. United States Ocular Drug Delivery Price by Application (2017-2028) & (USD/Dose)
    Figure 44. North America Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 45. North America Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. U.S. Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Canada Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Europe Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 49. Europe Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 50. Germany Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. France Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.K. Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Italy Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Russia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Asia-Pacific Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 56. Asia-Pacific Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 57. China Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Japan Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. South Korea Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. India Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Australia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Taiwan Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Indonesia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Thailand Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Malaysia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Philippines Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Latin America Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 68. Latin America Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Mexico Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Brazil Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Argentina Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Middle East & Africa Ocular Drug Delivery Sales in Volume Growth Rate 2017-2028 (K Doses)
    Figure 73. Middle East & Africa Ocular Drug Delivery Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 74. Turkey Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Saudi Arabia Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. U.A.E Ocular Drug Delivery Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Ocular Drug Delivery Value Chain
    Figure 78. Ocular Drug Delivery Production Process
    Figure 79. Channels of Distribution
    Figure 80. Distributors Profiles
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed